Fair Disease Diagnosis on PHAROS Challenge Task 2
62.5Male Macro F1FDVTS
Evaluation Results
| Method | Links | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDVTS2026.03 | 62.5 | — | — | — | — | — | — | — | — | 78.3 | 70.4 | |
| PHAROS Baseline2026.03 | 55.9 | — | — | — | — | — | — | — | — | 68.7 | 62.3 | |
| Group DROα=1.0, Loss=GDRO2026.03 | 0.8521 | 89.36 | 81.48 | 85 | 85 | 77.19 | 31.58 | 90.91 | 88.89 | 0.7214 | 0.7868 | |
| Group DROα=0.3, Loss=GDRO2026.03 | 0.822 | 88.89 | 70 | 85.71 | 84.21 | 83.33 | 37.5 | 90.48 | 89.47 | 0.752 | 0.787 | |
| Group DROα=0.5, Loss=GDRO2026.03 | 0.8085 | 86.79 | 66.67 | 84.21 | 85.71 | 85.19 | 63.64 | 90.91 | 88.89 | 0.8215 | 0.815 | |
| Group DROα=0.0, Loss=GDRO2026.03 | 0.8042 | 80 | 66.67 | 90 | 85 | 84.21 | 52.63 | 92.68 | 92.31 | 0.8046 | 0.8044 | |
| Weighted CELoss=WCE2026.03 | 0.7956 | 84.62 | 63.64 | 85 | 85 | 81.36 | 25 | 95.24 | 92.31 | 0.7348 | 0.7652 | |
| Focal (γ = 2)Loss=FL2026.03 | 0.7952 | 76.6 | 64.29 | 90 | 87.18 | 72 | 46.15 | 92.68 | 92.31 | 0.7579 | 0.7765 | |
| Group DROα=0.1, Loss=GDRO2026.03 | 0.7831 | 82.35 | 60.87 | 85 | 85 | 76.67 | 33.33 | 95.24 | 88.89 | 0.7353 | 0.7592 |